List of Excipients in API clorazepate dipotassium
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing clorazepate dipotassium
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| RECORDATI RARE DISEASES INC | TRANXENE | clorazepate dipotassium | 55292-302 | CELLULOSE, MICROCRYSTALLINE | |
| RECORDATI RARE DISEASES INC | TRANXENE | clorazepate dipotassium | 55292-302 | FD&C YELLOW NO. 6 | |
| RECORDATI RARE DISEASES INC | TRANXENE | clorazepate dipotassium | 55292-302 | MAGNESIUM OXIDE | |
| RECORDATI RARE DISEASES INC | TRANXENE | clorazepate dipotassium | 55292-302 | MAGNESIUM STEARATE | |
| RECORDATI RARE DISEASES INC | TRANXENE | clorazepate dipotassium | 55292-302 | POTASSIUM CARBONATE | |
| RECORDATI RARE DISEASES INC | TRANXENE | clorazepate dipotassium | 55292-302 | POTASSIUM CHLORIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing clorazepate dipotassium
Detailed excipient profiles for clorazepate dipotassium
Excipient focus: CELLULOSE, MICROCRYSTALLINE
clorazepate dipotassium drug variants containing CELLULOSE, MICROCRYSTALLINE
clorazepate dipotassium drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Contract Pharmacy Services-PA | clorazepate dipotassium | 67046-906 |
| >Company | >Ingredient | >NDC |
Excipient focus: COLLOIDAL SILICON DIOXIDE
clorazepate dipotassium drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | clorazepate dipotassium | 63304-552 |
| >Company | >Ingredient | >NDC |
clorazepate dipotassium drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSCARMELLOSE SODIUM
clorazepate dipotassium drug variants containing CROSCARMELLOSE SODIUM
clorazepate dipotassium drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: D&C RED NO. 6 BARIUM LAKE
clorazepate dipotassium drug variants containing D&C RED NO. 6 BARIUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| PD-Rx Pharmaceuticals Inc | clorazepate dipotassium | 43063-893 |
| PD-Rx Pharmaceuticals Inc | clorazepate dipotassium | 72789-256 |
| >Company | >Ingredient | >NDC |
clorazepate dipotassium drug variants not containing D&C RED NO. 6 BARIUM LAKE
Excipient focus: FD&C BLUE NO. 2
clorazepate dipotassium drug variants containing FD&C BLUE NO. 2
clorazepate dipotassium drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C BLUE NO. 2 ALUMINUM LAKE
clorazepate dipotassium drug variants containing FD&C BLUE NO. 2 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | clorazepate dipotassium | 60505-4754 |
| >Company | >Ingredient | >NDC |
clorazepate dipotassium drug variants not containing FD&C BLUE NO. 2 ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
clorazepate dipotassium drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | clorazepate dipotassium | 72162-2100 |
| >Company | >Ingredient | >NDC |
clorazepate dipotassium drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
Excipient focus: FD&C RED NO. 4 FREE ACID
clorazepate dipotassium drug variants containing FD&C RED NO. 4 FREE ACID
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | clorazepate dipotassium | 60505-4754 |
| Bryant Ranch Prepack | clorazepate dipotassium | 72162-2100 |
| >Company | >Ingredient | >NDC |
clorazepate dipotassium drug variants not containing FD&C RED NO. 4 FREE ACID
Excipient focus: FD&C RED NO. 40
clorazepate dipotassium drug variants containing FD&C RED NO. 40
clorazepate dipotassium drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
clorazepate dipotassium drug variants containing FD&C YELLOW NO. 6
clorazepate dipotassium drug variants not containing FD&C YELLOW NO. 6
Excipient focus: MAGNESIUM OXIDE
clorazepate dipotassium drug variants containing MAGNESIUM OXIDE
clorazepate dipotassium drug variants not containing MAGNESIUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
clorazepate dipotassium drug variants containing MAGNESIUM STEARATE
clorazepate dipotassium drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM CARBONATE
clorazepate dipotassium drug variants containing POTASSIUM CARBONATE
clorazepate dipotassium drug variants not containing POTASSIUM CARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM CHLORIDE
clorazepate dipotassium drug variants containing POTASSIUM CHLORIDE
clorazepate dipotassium drug variants not containing POTASSIUM CHLORIDE
Excipient focus: SILICON DIOXIDE
clorazepate dipotassium drug variants containing SILICON DIOXIDE
clorazepate dipotassium drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM CHLORIDE
clorazepate dipotassium drug variants containing SODIUM CHLORIDE
clorazepate dipotassium drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM LAURYL SULFATE
clorazepate dipotassium drug variants containing SODIUM LAURYL SULFATE
clorazepate dipotassium drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: TALC
clorazepate dipotassium drug variants containing TALC
clorazepate dipotassium drug variants not containing TALC
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
